Serine hydroxymethyltransferase 2 (SHMT2) potentiates the aggressive process of oral squamous cell carcinoma by binding to interleukin enhancer-binding factor 2 (ILF2)

Oral squamous cell carcinoma (OSCC) is a frequent threatening head and neck malignancy. Serine hydroxymethyltransferase 2 (SHMT2) was identified to be upregulated in OSCC and its high expression was associated with poor patient prognosis. This paper set out to assess the influence of SHMT2 on OSCC p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hui, Che, Yilei, Xuan, Bin, Wu, Xiaozhen, Li, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161932/
https://www.ncbi.nlm.nih.gov/pubmed/35333683
http://dx.doi.org/10.1080/21655979.2022.2051886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161932/
https://www.ncbi.nlm.nih.gov/pubmed/35333683
http://dx.doi.org/10.1080/21655979.2022.2051886

Ejemplares similares